HeraCARE Source: HeraMED
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • HeraMED (ASX:HMD) shares are surging following the announcement of a partnership agreement with Telstra Health
  • The collaboration aims to integrate HeraCARE into MedicalDirector Clinical by Telstra Health
  • Telstra Health currently lacks a remote pregnancy solution, but HeraCARE is filling this gap by offering comprehensive care, especially in rural areas
  • HMD Executive Chairman Ron Weinberger says the agreement is a “validation” of the company’s technology
  • HMD shares are up 4.35 per cent, trading at 4.8 cents at 1:20 pm AEDT

HeraMED (ASX:HMD) shares are surging today following the announcement of a partnership agreement with Australia’s largest e-health provider, Telstra Health.

The collaboration aims to integrate HeraCARE into MedicalDirector Clinical by Telstra Health, a widely used software among GPs who manage their clinics through Telstra Health.

MedicalDirector stands out as a top-notch clinical and practice management software solution, designed to enhance the delivery of care for GPs, specialists, nurses, and other healthcare professionals, fostering improved safety and efficiency.

Currently, Telstra Health lacks a remote pregnancy solution. HeraCARE aims to fill this gap, offering comprehensive care, especially in rural areas.

This aligns with HeraMED’s strategy to onboard more private clinics.

“After passing a rigorous assessment we are pleased to welcome HeraCARE to Telstra Health’s Smart Marketplace, enabling our primary care providers to provide prenatal healthcare through its remote monitoring and maternity care platform, helping improve the patient and clinician experience,” Telstra Health General Manager Ecosystem Louise Ryves said.

“This partner agreement represents [the] validation of our technology from one of the leading digital health operators globally,” HMD Executive Chairman Ron Weinberger said.

HeraMED’s collaboration with Telstra Health positions the company well for broader market reach, with the planned launch of HeraCARE for Telstra Health customers anticipated in the first quarter of calendar year 2024.

HMD shares were up 4.35 per cent, trading at 4.8 cents at 1:20 pm AEDT.

HMD by the numbers
More From The Market Online
medical patient

Drove autonomous wheelchair gets TGA approval

Control Bionics (ASX: CBL) has announced that its autonomous wheelchair module, DROVE, has been officially included as a Class 1 Medical Device

Green Technology hands the helm to Henry

Green Technology Metals, a Canadian-focused multi-asset lithium business, has appointed Mr. Cameron Henry as Managing Director.

Singaporean Olam’s bid to buyout Naomi Cotton raises ACCC alarms – lots of them

The ACCC has taken issue with Naomi Cotton's (ASX:NAM) proposed takeover by Singaporean Olam. Its concerns…

ASX Market Open: Lower trading and political nerves in Europe push Aus market down | 20 June 2024

Australian futures opened slightly down today, following European stocks which were down overnight on political tensions.